Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Illuminant Surgical has raised $8.4 million in seed funding led by Wing 2 Wing Ventures to accelerate the launch of its Skylight platform, a projection-based system that displays internal anatomy directly on the patient's body without the need for headsets or monitors.
Verana Health has introduced the world's largest curated real world dataset for prostate cancer, compiled from over 430,000 patients and drawn from the American Urological Association Quality Registry.
White Plume reports that most AI tools in ambulatory revenue cycle management target the wrong financial layer, leaving more than $170 billion in annual value unrecognized. The company’s STAR² Ai platform focuses on pre-submission decision quality to recover missed revenue before claims are created.
Medisolv has acquired Health Elements AI to improve how healthcare organizations capture and use clinical data for quality reporting and registries. The acquisition aims to reduce manual chart review workloads and broaden Medisolv's analytics capabilities.
SanLuca has partnered with Sutter Health to integrate cognitive behavioral therapy into hypertension management through the Sutter Sync program, combining AI-led virtual care with clinical oversight to support behavioral and physical health outcomes.
AiZtech Labs has launched iSelfie BioSignals in the U.S., a smartphone-based platform that captures clinical data through selfies to assist healthcare providers with faster triage and intake.
ProviderTrust and J.D. Palatine have announced a partnership to integrate background checks and eligibility verification into healthcare hiring, improving compliance and efficiency.
Carrum Health has appointed Kulesh Shanmugasundaram as Chief Product and Technology Officer and Ravi Garimella as Senior Vice President of Data and AI to strengthen its AI and data infrastructure as the company scales its specialty care platform.
Arizton forecasts that the Europe laboratory information systems market will reach USD 689.05 million by 2031, driven by AI adoption and digital modernization in laboratory operations.
Haier Biomedical reported 2025 annual revenue of 2.33 billion yuan, with overseas operations contributing a record 36 percent of total revenue. The company highlighted growth in AI applications, new product certifications, and expanded global presence.
Hangzhou-based Diagens reported RMB 164 million in annual revenue for its first year since listing, a 133.7% increase, with licensing from its iMedImage foundation model emerging as the main growth driver.
Caris Life Sciences has published a peer-reviewed study validating its AI-based predictive signature for temozolomide benefit in glioblastoma patients, showing strong concordance with traditional MGMT methylation testing.
Valeris and Fuze Health have agreed to collaborate on integrating digital pharmacy capabilities with patient access and support services. The partnership aims to accelerate therapy initiation and improve coordination across the patient journey.
Zingage has integrated its AI agents with HHAeXchange’s Partner Connect program, giving over 32,000 home care providers access to automation tools for scheduling, phone operations, and compliance management.
SnapCare and connectRN have merged to address healthcare staffing challenges, combining their platforms and clinician networks. The new company also secured Series A funding led by Suvretta Capital to support product innovation and growth.
RIVANNA reported that its Accuro XV ultrasound system produced diagnostic-quality images of extremity injuries when used by non-physicians after brief training, according to a published study.
Complete Genomics announced that AI trained variant calling models reduced genome analysis errors by up to 73 percent compared to standard methods on its DNBSEQ sequencing platform.
DeepLook Medical has won top honors at the 2026 Venture Madness competition for its AI imaging technology that enhances early cancer detection. The company, supported by Xcellerant Ventures, has expanded its operations in Arizona and will conduct upcoming clinical trials with Banner MD Anderson.
Paradigm Health has launched a collaboration with the FDA to develop a model for real time regulatory review of clinical trial data. The project involves trials sponsored by Amgen and AstraZeneca and aims to automate data collection and reporting to speed up reviews.
ACROBiosystems presented its AI-based protein engineering platforms at the AACR Annual Meeting 2026, introducing its Acro-AIx system and related models for protein design and optimization.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
